Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10801
PUT
Kyverna Therapeutics
KYTX
$505M
| $102K | ﹤0.01% |
13,600
+6,300
| +86% | +$96.3K |
|
10802
Ryan Specialty Holdings
RYAN
$10.7B
| $102K | ﹤0.01% |
1,761
-89,438
| -98% | -$4.77M |
|
|
MRCC
10803
PUT
DELISTED
Monroe Capital Corp
MRCC
| $102K | ﹤0.01% |
13,400
-200
| -1% | -$1.48K |
|
|
TBNK
10804
DELISTED
Territorial Bancorp Inc.
TBNK
| $102K | ﹤0.01% |
+12,579
| New | +$97.9K |
|
10805
CALL
MeiraGTx Holdings
MGTX
$1.3B
| $102K | ﹤0.01% |
24,200
+20,900
| +633% | +$105K |
|
10806
Nuveen California Municipal Value Fund
NCA
$303M
| $102K | ﹤0.01% |
+11,748
| New | +$102K |
|
10807
CALL
Banco de Chile
BCH
$20.6B
| $102K | ﹤0.01% |
4,500
-1,200
| -21% | -$27.7K |
|
10808
PUT
California Water Service
CWT
$3.12B
| $102K | ﹤0.01% |
2,100
-6,500
| -76% | -$316K |
|
10809
PUT
Global X SuperDividend US ETF
DIV
$786M
| $102K | ﹤0.01% |
5,900
+3,600
| +157% | +$61.9K |
|
10810
CALL
KNOT Offshore Partners
KNOP
$369M
| $102K | ﹤0.01% |
11,600
+9,400
| +427% | +$56.3K |
|
10811
PUT
Atomera
ATOM
$219M
| $102K | ﹤0.01% |
26,700
-31,600
| -54% | -$149K |
|
10812
PUT
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $102K | ﹤0.01% |
4,000
-600
| -13% | -$15.2K |
|
|
IOBT
10813
DELISTED
IO Biotech
IOBT
| $102K | ﹤0.01% |
86,894
+28,272
| +48% | +$39.5K |
|
10814
CALL
Alignment Healthcare
ALHC
$2.9B
| $102K | ﹤0.01% |
13,000
+8,500
| +189% | +$55.5K |
|
|
VMEO
10815
PUT
DELISTED
Vimeo
VMEO
| $101K | ﹤0.01% |
27,200
-14,600
| -35% | -$55.2K |
|
10816
PUT
Investcorp Credit Management BDC
ICMB
$12.1M
| $101K | ﹤0.01% |
30,100
+27,900
| +1,268% | +$90.6K |
|
|
NTST
10817
PUT
NETSTREIT Corp
NTST
$2.1B
| $101K | ﹤0.01% |
6,300
+4,200
| +200% | +$72.2K |
|
10818
PUT
Xeris Biopharma Holdings
XERS
$1.57B
| $101K | ﹤0.01% |
45,000
-35,400
| -44% | -$71.3K |
|
10819
PUT
Ligand Pharmaceuticals
LGND
$5.87B
| $101K | ﹤0.01% |
1,200
-4,900
| -80% | -$390K |
|
10820
RPM International
RPM
$14.5B
| $101K | ﹤0.01% |
939
-33,716
| -97% | -$3.73M |
|
|
QIPT
10821
CALL
DELISTED
Quipt Home Medical
QIPT
| $101K | ﹤0.01% |
31,400
+29,400
| +1,470% | +$105K |
|
10822
CALL
Ginkgo Bioworks
DNA
$457M
| $101K | ﹤0.01% |
7,558
+1,843
| +32% | +$55K |
|
10823
PUT
VirTra
VTSI
$36.6M
| $101K | ﹤0.01% |
13,100
+9,700
| +285% | +$112K |
|
|
ONIT
10824
CALL
Onity Group
ONIT
$328M
| $101K | ﹤0.01% |
4,200
-300
| -7% | -$7.39K |
|
|
UCFI
10825
CN Healthy Food Tech Group
UCFI
| $101K | ﹤0.01% |
+10,006
| New | +$101K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.